Chemomab Therapeutics Ltd.

What is Chemomab Therapeutics Ltd. (CMMB) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Chemomab Therapeutics Ltd. (CMMB) stock is trading at $2.06. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CMMB stock quotes for informed trading decisions.

What is Chemomab Therapeutics Ltd.'s market capitalization?

Chemomab Therapeutics Ltd. (CMMB) has a market capitalization of approximately $12.7M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Chemomab Therapeutics Ltd.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CMMB stock price changes.

What is the 52-week range for Chemomab Therapeutics Ltd. stock?

Chemomab Therapeutics Ltd. (CMMB) stock has traded in a 52-week range of $2.01 — $9.84. The 52-week range shows the highest and lowest prices at which CMMB traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Chemomab Therapeutics Ltd. stock price to this range provides context for recent price action.

How much trading volume does Chemomab Therapeutics Ltd. stock have?

Chemomab Therapeutics Ltd. (CMMB) stock recently traded approximately 84.6K shares. Trading volume indicates market liquidity and investor interest in CMMB. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Chemomab Therapeutics Ltd. stock.

Does Chemomab Therapeutics Ltd. pay dividends to shareholders?

Yes, Chemomab Therapeutics Ltd. (CMMB) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Chemomab Therapeutics Ltd. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Chemomab Therapeutics Ltd.'s intraday price range?

Today, Chemomab Therapeutics Ltd. (CMMB) stock has traded in a range of $2.03 — $2.11. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CMMB's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Chemomab Therapeutics Ltd. stock data?

AlphaPilot sources real-time CMMB stock quotes, fundamental financial data, and historical price charts for Chemomab Therapeutics Ltd. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Chemomab Therapeutics Ltd. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CMMB stock performance.